Parallax Volatility Advisers
ALT icon

Parallax Volatility Advisers’s Altimmune ALT Stock Holding History

Parallax Volatility Advisers’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,800
Closed -$161K – 2688
2022
Q4 		$161K Hold
9,800
– – ﹤0.01% 2190
2022
Q3 		$125K Buy
+9,800
New +$145K ﹤0.01% 2426
2021
Q4 		– Sell
-68,900
Closed -$779K – 2965
2021
Q3 		$779K Buy
+68,900
New +$838K ﹤0.01% 2084
2021
Q2 		– Sell
-50,000
Closed -$707K – 2941
2021
Q1 		$707K Hold
50,000
– – ﹤0.01% 2235
2020
Q4 		$564K Buy
+50,000
New +$589K ﹤0.01% 2434

Other funds holding ALT

Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Parallax Volatility Advisers's ALT Position: Q4 2021 in Review

Parallax Volatility Advisers sold out of Altimmune (ALT) in Q4 2021, closing a stake of 57,130 shares — an estimated $646K sold.

Parallax Volatility Advisers first reported a position in ALT in Q4 2020 and held it in 3 quarters. The position peaked at $646K in Q3 2021. 102 funds tracked by Wall St. Rank hold ALT as of Q4 2021.

  • Parallax Volatility Advisers reported no remaining Altimmune position as of Q4 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 57,130 Altimmune shares in Q4 2021, an estimated $646K.
  • Parallax Volatility Advisers first reported a position in Altimmune in Q4 2020 and held it in 3 quarters.
  • Parallax Volatility Advisers's Altimmune position peaked at $646K in Q3 2021.
  • 102 funds tracked by Wall St. Rank held Altimmune as of Q4 2021.

Based on Parallax Volatility Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.